Literature DB >> 17728332

Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions.

D van der Heijde1, R Landewé, E Feldtkeller.   

Abstract

BACKGROUND: The Bath Ankylosing Spondylitis Metrology Index (BASMI) characterises the spinal mobility of patients with ankylosing spondylitis. Two versions have been published using categorical scores with either scores 0-2 for each of the five assessments, or scores 0-10. For metric purposes, we recently defined a BASMI version with linear score definitions. AIM: to evaluate agreement between three BASMI definitions and to test sensitivity to change. PATIENTS AND METHODS: The performance of the BASMI(2) (based on the 2-step definition), BASMI(10) (based on the 10-step definition), and BASMI(lin) (based on the linear definition), are compared in 598 status assessments and 222 follow-up assessments with a 24-week interval after an intervention with either placebo or a tumour necrosis factor (TNF) blocker from various cohorts of patients with ankylosing spondylitis (AS). Descriptive statistics and Bland-Altman plots were applied to compare the pairwise agreement of the three definitions. To assess sensitivity to change, Guyatt effect size using change data from the placebo and actively treated patients were used.
RESULTS: Bland-Altman analysis showed that the differences between BASMI(2) scores and scores obtained by either of the two other definitions were highly dependent on the magnitude of the measurement. Guyatt effect sizes were 0.66 for the BASMI(2), 0.95 for the BASMI(10), and 1.04 for the BASMI(lin), respectively, demonstrating best sensitivity to change for the newly-developed BASMI(lin).
CONCLUSIONS: The BASMI(10) and BASMI(lin) have clear metric advantages as compared to BASMI(2), among which are their superior sensitivity to change and feasibility of BASMI(lin) in computer evaluations. The BASMI(10) and BASMI(2) are not interchangeable.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728332     DOI: 10.1136/ard.2007.074724

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  36 in total

Review 1.  [Tapering and termination of immunosuppressive treatment in spondyloarthritides (including psoriatic arthritis)].

Authors:  G Scholz; B Möller
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

2.  Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi; Farhad Gharibdoost; Mahdi I Mahmoud; Pedram Paragomi; Mohammad Hossein Nicknam; Elham Farhadi; Mostafa Qorbani
Journal:  Caspian J Intern Med       Date:  2012

3.  Evaluation of spinal mobility measurements in predicting axial psoriatic arthritis.

Authors:  Ying-ying Leung; Kwok Wah Ho; Lai Shan Tam; Tracy Y Zhu; Lai W Kwok; Tena K Li; Emily W Kun; Edmund K Li
Journal:  Clin Rheumatol       Date:  2011-03-03       Impact factor: 2.980

4.  Normal range of spinal mobility for healthy young adult Turkish men.

Authors:  Muharrem Cidem; Ilhan Karacan; Murat Uludag
Journal:  Rheumatol Int       Date:  2011-05-05       Impact factor: 2.631

5.  The gait deviations of ankylosing spondylitis with hip involvement.

Authors:  Guoning Zhang; Jia Li; Zhengliang Xia; Weidong Xu
Journal:  Clin Rheumatol       Date:  2019-01-04       Impact factor: 2.980

6.  Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study.

Authors:  Dirk Ziebolz; David Douglas; Donya Douglas; Jan Schmickler; Daniel Patschan; Gerhard A Müller; Rainer Haak; Jana Schmidt; Gerhard Schmalz; Susann Patschan
Journal:  Rheumatol Int       Date:  2018-03-20       Impact factor: 2.631

Review 7.  [Ankylosing spondylitis. Target treatment criteria].

Authors:  J Braun; J Sieper
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

Review 8.  Clinical assessment and outcome research in spondyloarthritis.

Authors:  Robert B M Landewé; Astrid van Tubergen
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

9.  Comparison between the intermalleolar distance measured on the couch and on the floor in axial spondyloarthritis.

Authors:  James K J Diss; Andreas Georgiou; Euthalia Roussou
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

10.  The Bath metrology index as assessed by a trained and an untrained rater in patients with spondylarthropathy: a study of intra- and inter-rater agreements.

Authors:  O R Madsen; L B Hansen; A Rytter; C Suetta; C Egsmose
Journal:  Clin Rheumatol       Date:  2008-08-26       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.